awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35843507-E66A84C9-3AD6-4EF5-B2BE-1EDE14830868
Q35843507-E66A84C9-3AD6-4EF5-B2BE-1EDE14830868
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35843507-E66A84C9-3AD6-4EF5-B2BE-1EDE14830868
Challenges and future perspectives of T cell immunotherapy in cancer
P2860
Q35843507-E66A84C9-3AD6-4EF5-B2BE-1EDE14830868
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35843507-E66A84C9-3AD6-4EF5-B2BE-1EDE14830868
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e71a6494ecbbb4d5f532da801e6466468011d844
P2860
FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer.